Sherwin Williams

Sherwin-Williams closed up 2.25% to $317.51 today, driven primarily by strong Q1 earnings results and sustained analyst backing; the company reported Q1 revenue of $5.67 billion, up 6.81% year-over-year, alongside improved net profit margin of 9.44% and earnings per share of $2.15, up 7.5% YoY, demonstrating robust operational execution and margin expansion. Although the Q3 dividend declaration came in below market expectations and initially weighed on pre-market sentiment, intraday buying pressure quickly reasserted control, pushing the stock to an intraday high of $319.82; sell-side analysts have maintained their buy rating with a $385 price target, offering approximately 21% upside potential from present levels. Year-to-date performance shows a 3.15% decline, with shares trading roughly 16% below the 52-week high of $379.65, at current P/E valuation of 30.22x reflecting a moderate risk-reward positioning.

Sherwin-Williams declined approximately 6.2% in pre-market to $300.03, weighed down by a newly announced $0.80 dividend per share that fell short of market expectations and lukewarm analyst sentiment. The stock recovered partially during the regular session to close at $310.54, down 2.9% from the prior close of $319.91. From a fundamentals perspective, Q1 2026 showed operating revenue of $5.67 billion, up 6.81% year-over-year, net profit of $534.7 million up 6.11%, and EPS of $2.15 up 7.5%, indicating solid earnings growth. However, valuation metrics appear stretched with a P/E of 29.55 at elevated levels; the stock has fallen 18.2% from its 52-week high of $379.65 and is down 5.28% year-to-date, trading below its 20-day moving average of $334.50. On the positive side, analysts maintain a $385 price target, suggesting 24% upside potential from current levels.

Sherwin-Williams rose 0.46% to $319.91 today, primarily supported by solid Q1 results: revenue of $5.67 billion grew 6.81% year-over-year, EPS of $2.15 grew 7.5% year-over-year, and net margin expanded to 9.44%. The company also declared a quarterly dividend of $0.80 per share. Regarding valuation metrics, the stock trades 15.74% below its 52-week high, has declined 2.42% year-to-date, but remains above its 60-day moving average. Analysts maintained a buy rating with a $385 price target, suggesting approximately 20% upside. Intraday action was modest—the stock dipped to $317 in pre-market trading, then recovered to a high of $322.76 during the regular session, ultimately closing near yesterday's level, reflecting cautious market sentiment. However, elevated valuation multiples of PE 30.44 and PB 17.86 may limit near-term gains.

SHW declined 1.59% to $318.46 despite a 4.24% pre-market surge, as intraday and post-market weakness reflected profit-taking following the earlier rally. Fundamentals remain solid with Q1 revenue of $5.67 billion (up 6.81% YoY), EPS of $2.15 (up 7.5% YoY), and a strong 47.37% ROE, alongside 5.93% operating income growth. However, the stock has retreated 16.12% from its 52-week high of $379.65 and trades below its 20-day moving average at $335.78, with a PE of 30.31x suggesting elevated valuations. Analysts reaffirmed a Buy rating with a $385 price target, providing upside support, while Sherwin-Williams has adopted Square payment features for its professional customers, signaling operational progress. That said, competitive headwinds—as the stock's underperformance versus peers indicates—combined with high valuation multiples and the gradual absorption of recent strategic initiatives, may constrain near-term momentum despite constructive earnings.

SHW shares declined approximately 2% today, driven by institutional portfolio rebalancing and profit-taking pressure following earlier strength. Pre-market trading initially pushed the stock to $333, but regular-session selling accelerated the decline to $323.60 intraday before a modest post-market recovery to $324. Institutional selling pressure emerged as Copeland Capital Management announced a reduction in its holdings, weighing on sentiment. Nevertheless, the company's business fundamentals remain solid. Most recent Q1 results demonstrated operational momentum with revenue reaching $56.67 billion, up 6.81% year-over-year, while earnings per share of $2.15 grew 7.5% year-over-year, with net profit margin expanding to 9.44%. Sell-side analysts maintained their Buy rating with a $385 price target, implying meaningful upside from current levels. However, elevated valuation multiples—P/E at 30.8 and P/B at 18.06—reflect high growth expectations already priced in, with shares trading 14.76% below the 52-week high of $379.65 and below the 20-day moving average of $335.70.